Q1 2024 Holdings
Filed 2024-05-13 | 12 holdings | $378.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $152.8M | 10,360,945 | 40.4% |
| Alimera Sciences Inc | COM NEW | 016259202 | $65.7M | 16,835,154 | 17.4% |
| Anika Therapeutics Inc(ANIK) | COM | 035255108 | $36.5M | 1,435,993 | 9.6% |
| Evolus Inc(EOLS) | COM | 30052C107 | $26.4M | 1,888,881 | 7.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $26.1M | 1,100,730 | 6.9% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $20.9M | 1,296,447 | 5.5% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $15.0M | 858,070 | 4.0% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $14.2M | 484,711 | 3.7% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $9.5M | 587,276 | 2.5% |
| Outlook Therapeutics Inc(OTLK) | COM | 69012T305 | $6.0M | 500,000 | 1.6% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $3.9M | 758,502 | 1.0% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $1.4M | 756,538 | 0.4% |